HK160995A - Complex compounds of bioflavonoids with phospholipids their preparation and use and pharmaceutical and cosmetic compositions containing them - Google Patents

Complex compounds of bioflavonoids with phospholipids their preparation and use and pharmaceutical and cosmetic compositions containing them

Info

Publication number
HK160995A
HK160995A HK160995A HK160995A HK160995A HK 160995 A HK160995 A HK 160995A HK 160995 A HK160995 A HK 160995A HK 160995 A HK160995 A HK 160995A HK 160995 A HK160995 A HK 160995A
Authority
HK
Hong Kong
Prior art keywords
complex compounds
phospholipids
pharmaceutical
cosmetic compositions
bioflavonoids
Prior art date
Application number
HK160995A
Other languages
English (en)
Inventor
Ezio Bombardelli
Gian Franco Patri
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Publication of HK160995A publication Critical patent/HK160995A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/10—Phosphatides, e.g. lecithin
    • C07F9/106—Adducts, complexes, salts of phosphatides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/543—Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
    • A61K47/544—Phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A61K8/553—Phospholipids, e.g. lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9771—Ginkgophyta, e.g. Ginkgoaceae [Ginkgo family]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/06—Benzopyran radicals
    • C07H17/065—Benzo[b]pyrans
    • C07H17/07—Benzo[b]pyran-4-ones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Botany (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Dermatology (AREA)
  • Genetics & Genomics (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Saccharide Compounds (AREA)
  • Pyrane Compounds (AREA)
HK160995A 1987-01-14 1995-10-12 Complex compounds of bioflavonoids with phospholipids their preparation and use and pharmaceutical and cosmetic compositions containing them HK160995A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT19081/87A IT1201149B (it) 1987-01-14 1987-01-14 Complessi di bioflavonoidi con fosfolipidi,loro preparazione,uso e composizioni farmaceutici e cosmetiche

Publications (1)

Publication Number Publication Date
HK160995A true HK160995A (en) 1995-10-20

Family

ID=11154385

Family Applications (1)

Application Number Title Priority Date Filing Date
HK160995A HK160995A (en) 1987-01-14 1995-10-12 Complex compounds of bioflavonoids with phospholipids their preparation and use and pharmaceutical and cosmetic compositions containing them

Country Status (8)

Country Link
US (1) US5043323A (es)
EP (1) EP0275005B1 (es)
JP (1) JP2848827B2 (es)
AT (1) ATE92929T1 (es)
DE (1) DE3883016T2 (es)
ES (1) ES2058139T3 (es)
HK (1) HK160995A (es)
IT (1) IT1201149B (es)

Families Citing this family (103)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1201151B (it) * 1987-01-14 1989-01-27 Indena Spa Complessi fosfolipidici con estratti da vitis vinifera,procedimento per la loro preparazione e composizioni che li cntengono
US5637302A (en) * 1988-09-20 1997-06-10 Indena Spa Extracts of Ginkgo biloba and their methods of preparation
FR2639828B1 (fr) * 1988-12-01 1993-11-05 Lvmh Recherche Utilisation du kaempferol et de certains de ses derives pour la preparation d'une composition cosmetique ou pharmaceutique
IT1238684B (it) * 1990-02-09 1993-09-01 Indena Spa Derivati del bilobalide,loro usi e formulazioni che li contegono
FR2661830B1 (fr) * 1990-05-11 1992-09-04 Corbiere Jerome Nouvelle compositions pharmaceutiques a base de flavonoside.
ES2072416T3 (es) * 1990-07-05 1995-07-16 Indena Spa Complejos de derivados de neolignano con fosfolipidos, su uso y formulaciones farmaceuticas y cosmeticas que los contienen.
FR2667505B1 (fr) * 1990-10-08 1993-01-15 Thorel Jean Noel Bases pour serums a usage cosmetique.
FR2668705A1 (fr) * 1990-11-06 1992-05-07 Bouchara Sa Nouvelles preparations dermiques a action phlebotonique et leur procede de preparation.
FR2669537B1 (fr) * 1990-11-28 1993-02-19 Oreal Composition amincissante a base d'alpha-2-bloqueurs.
US5455232A (en) * 1992-02-04 1995-10-03 Piljac; Goran Pharmaceutical preparation based on rhamnolipid
US5401728A (en) * 1992-04-02 1995-03-28 Simon; John A. Lecithin based topical liniment
GB9211659D0 (en) * 1992-06-02 1992-07-15 Indena Spa New alkaloid derivatives,their use and pharmaceutical formulations containing them
FR2692145B1 (fr) * 1992-06-10 1995-05-05 Bellon Labor Sa Roger Nouvelle composition à usage topique contenant de la diosmine.
AU4792993A (en) * 1992-07-30 1994-03-03 Andrew Stone Dialysis system, method and filtrate solution composition
FR2697159B1 (fr) * 1992-10-22 1995-01-13 Oreal Composition cosmétique ou dermo-pharmaceutique contenant en association un lauroylméthionate d'un amino acide basique et au moins un polyphénol.
FR2699818B1 (fr) * 1992-12-24 1995-02-03 Oreal Composition cosmétique ou pharmaceutique contenant en association un polyphénol et un extrait de gingko.
IL105244A (en) * 1993-03-31 2003-07-31 Dpharm Ltd Prodrugs with enhanced penetration into cells
US6413949B1 (en) * 1995-06-07 2002-07-02 D-Pharm, Ltd. Prodrugs with enhanced penetration into cells
HUT67748A (en) * 1993-07-27 1995-04-28 Biogal Gyogyszergyar Hair tonic composition
FR2719468B1 (fr) * 1994-05-05 1996-05-31 Oreal Compositions cosmétiques à base de certains bioflavonoïdes et utilisations notamment dans le domaine capillaire.
FR2719467B1 (fr) * 1994-05-05 1996-05-31 Oreal Utilisation de flavonoïdes pour préserver et/ou renforcer les propriétés mécaniques des cheveux et procédé de protection des cheveux utilisant ces composés.
FR2726469B1 (fr) * 1994-11-08 1996-12-13 Adir Composition pharmaceutique pour l'administration orale de flavonoides
DE4444238A1 (de) * 1994-12-13 1996-06-20 Beiersdorf Ag Kosmetische oder dermatologische Wirkstoffkombinationen aus Zimtsäurederivaten und Flavonglycosiden
JPH11501311A (ja) * 1995-03-08 1999-02-02 パルファン、クリスチャン、ディオール 皮膚イソホスホジエステラーゼの阻害剤を含んでなる皮膚疾患を治療するための組成物
US6313106B1 (en) 1995-06-07 2001-11-06 D-Pharm Ltd. Phospholipid derivatives of valproic acid and mixtures thereof
EP1245230A3 (en) * 1995-06-23 2003-11-26 Advanced Life Sciences Inc. Amentoflavone as an antiviral agent
FR2736829B1 (fr) * 1995-07-20 1997-09-12 Oreal Composition pour lutter contre les taches et/ou le vieillissement de la peau, ses utilisations
US5571503A (en) * 1995-08-01 1996-11-05 Mausner; Jack Anti-pollution cosmetic composition
US5891465A (en) * 1996-05-14 1999-04-06 Biozone Laboratories, Inc. Delivery of biologically active material in a liposomal formulation for administration into the mouth
FR2749303B1 (fr) * 1996-05-30 1998-08-07 Berkem Sa Procede d'extraction de polyphenols catechiques a partir de potentilles extrait obtenu et son utilisation
FR2755012A1 (fr) * 1996-10-31 1998-04-30 Slow Age Creations Composition topique destinee a augmenter la souplesse et l'elasticite du buste pendant la phase premenstruelle
ATE275834T1 (de) 1997-03-20 2004-10-15 Coventry Group Ltd Nährungsergänzungsmittel für kardiovasküläre gesundheit
JP4231559B2 (ja) * 1997-04-23 2009-03-04 オリザ油化株式会社 リポキシゲナーゼ阻害剤
US8039026B1 (en) 1997-07-28 2011-10-18 Johnson & Johnson Consumer Companies, Inc Methods for treating skin pigmentation
US5958104A (en) * 1997-09-11 1999-09-28 Nonomura; Arthur M. Methods and compositions for enhancing plant growth
US6312703B1 (en) 1998-02-06 2001-11-06 Lecigel, Llc Compressed lecithin preparations
EP1063966A1 (en) * 1998-03-16 2001-01-03 The Procter & Gamble Company Methods for regulating skin appearance
US20080153761A1 (en) * 1998-04-08 2008-06-26 Theoharides Theoharis C Compositions for protection against superficial vasodilator flush syndrome, and methods of use
DE19829516B4 (de) * 1998-07-02 2004-08-26 Dr. Willmar Schwabe Gmbh & Co. Kg Wasserlöslicher nativer Trockenextrakt aus Gingko biloba mit hohem Gehalt an Terpenoiden und Flavonglykosiden
US6750229B2 (en) 1998-07-06 2004-06-15 Johnson & Johnson Consumer Companies, Inc. Methods for treating skin pigmentation
US8106094B2 (en) 1998-07-06 2012-01-31 Johnson & Johnson Consumer Companies, Inc. Compositions and methods for treating skin conditions
US8093293B2 (en) 1998-07-06 2012-01-10 Johnson & Johnson Consumer Companies, Inc. Methods for treating skin conditions
DE19845319A1 (de) * 1998-10-01 2000-04-06 Beiersdorf Ag Verwendung von oberflächenaktiven Substanzen zur Stabilisierung von Flavonen, Flavanonen bzw. Flavonoiden, synergistische Gemische aus Flavonen, Flavanonen bzw. Flavonoiden und oberflächenaktiven Substanzen sowie kosmetische und dermatologische Zubereitungen mit einem Gehalt an solchen Gemischen
IT1304183B1 (it) * 1998-12-18 2001-03-08 Indena Spa Complessi di proantocianidina a2 con fosfolipidi come agentiantiaterosclerotici.
US7985404B1 (en) 1999-07-27 2011-07-26 Johnson & Johnson Consumer Companies, Inc. Reducing hair growth, hair follicle and hair shaft size and hair pigmentation
WO2001021608A2 (en) * 1999-09-23 2001-03-29 Vereniging Voor Christelijk Wetenschappelijk Onderwijs Novel flavonoids
US6528042B1 (en) 1999-10-08 2003-03-04 Galileo Laboratories, Inc. Compositions of flavonoids for use as cytoprotectants and methods of making and using them
US6426362B1 (en) 1999-10-08 2002-07-30 Galileo Laboratories, Inc. Formulations of tocopherols and methods of making and using them
US7309688B2 (en) 2000-10-27 2007-12-18 Johnson & Johnson Consumer Companies Topical anti-cancer compositions and methods of use thereof
DE19962345B4 (de) * 1999-12-23 2005-03-17 Cognis Deutschland Gmbh & Co. Kg Kosmetische Mittel mit Pflanzenextrakten aus den Samenhäutchen von Arachis hypogaea L. und Verwendung der Pflanzenextrakte
GB2368012A (en) * 2000-10-19 2002-04-24 Nicholas John Larkins Preparation for the relief of inflammatory disease
US8431550B2 (en) 2000-10-27 2013-04-30 Johnson & Johnson Consumer Companies, Inc. Topical anti-cancer compositions and methods of use thereof
US6733797B1 (en) * 2000-11-15 2004-05-11 William K. Summers Neuroceutical for improving memory and cognitive abilities
US6555573B2 (en) * 2000-12-21 2003-04-29 The Quigley Corporation Method and composition for the topical treatment of diabetic neuropathy
US7368555B2 (en) * 2001-01-03 2008-05-06 Ceres, Inc. Sequence-determined DNA fragments encoding EF-hand calcium-binding proteins
KR20020069539A (ko) * 2001-02-26 2002-09-05 주식회사 두산 뇌세포 보호용 조성물
US6555143B2 (en) 2001-02-28 2003-04-29 Johnson & Johnson Consumer Products, Inc. Legume products
US7192615B2 (en) 2001-02-28 2007-03-20 J&J Consumer Companies, Inc. Compositions containing legume products
WO2003011873A2 (en) 2001-07-27 2003-02-13 Neptune Technologies & Bioressources Inc. Natural marine source phospholipids comprising flavonoids, polyunsaturated fatty acids and their applications
WO2003068210A1 (en) * 2002-02-12 2003-08-21 Hunza Di Pistolesi Elvira & C. S.A.S. N-acyl-phosphatidyl-ethanolamines and/or mixtures of n-acyl-ethanolamines with phosphatidic acids or lysophosphatidic acids
US7314634B2 (en) * 2002-02-22 2008-01-01 Steven Hernandez Use of polyphenols to treat skin conditions
US20040001817A1 (en) * 2002-05-14 2004-01-01 Giampapa Vincent C. Anti-aging nutritional supplement
US7083813B2 (en) * 2002-11-06 2006-08-01 The Quigley Corporation Methods for the treatment of peripheral neural and vascular ailments
ITMI20031789A1 (it) * 2003-09-19 2005-03-20 Indena Spa Composizioni farmaceutiche e cosmetiche per il trattamento
US8052992B2 (en) 2003-10-22 2011-11-08 Enzymotec Ltd. Glycerophospholipids containing omega-3 and omega-6 fatty acids and their use in the treatment and improvement of cognitive functions
US7935365B2 (en) 2003-10-22 2011-05-03 Enzymotec, Ltd. Glycerophospholipids for the improvement of cognitive functions
US20050130937A1 (en) 2003-10-22 2005-06-16 Enzymotec Ltd. Lipids containing omega-3 and omega-6 fatty acids
EP1541037A1 (de) * 2003-12-04 2005-06-15 Cognis Deutschland GmbH & Co. KG Zubereitung zur oralen Aufnahme enthaltend Extrakte von Passiflora incarnata
EP1559430B1 (en) 2004-01-29 2009-04-15 INDENA S.p.A. Use of ginkgo complexes for the enhancement of cognitive functions and the alleviation of mental fatigue
JP5089887B2 (ja) * 2006-01-23 2012-12-05 日本精化株式会社 生理活性物質含有複合体
EP1837030A1 (en) 2006-03-09 2007-09-26 INDENA S.p.A. Phospholipid complexes of curcumin having improved bioavailability
AU2007227535A1 (en) * 2006-03-15 2007-09-27 Rutgers, The State University Of New Jersey Hydroxylated polymethoxyflavone compositions
ITMI20060712A1 (it) 2006-04-11 2007-10-12 Fond Irccs Istituto Di Ricovero E Cura ... Uso di aminaftone per la preparazione di un medicamento per il trattamento delle arteriopatie
EP1844785A1 (en) * 2006-04-13 2007-10-17 Indena S.P.A. Phospholipid complexes of olive fruits or leaves extracts having improved bioavailability
WO2008019985A1 (en) * 2006-08-14 2008-02-21 Unilever Plc Method of purifying theaflavins
JP4757157B2 (ja) * 2006-09-20 2011-08-24 日本コルマー株式会社 皮膚外用剤
WO2010077165A1 (en) * 2008-12-31 2010-07-08 Obschestvo S Ogranichennoi Otvetstvennostju Scientific Company Flamena Phospholipid emulsion containing dihydroquercetin, and method of producing thereof
IT1395351B1 (it) 2009-07-09 2012-09-14 Axioma Srl Formulazioni orali ad elevata biodisponibilita' orale costituite da miscele di frazioni lipofile e idrofile ottenute a partire dalla propoli
CN102625693B (zh) 2009-08-26 2015-06-03 玫琳凯有限公司 包含植物提取物的局部皮肤护理配方
US8637569B2 (en) 2009-10-22 2014-01-28 Api Genesis, Llc Methods of increasing solubility of poorly soluble compounds and methods of making and using formulations of such compounds
BR112012011336A2 (pt) 2009-10-22 2018-10-16 Api Genesis Llc Composições compreendendo flavonoides, seu método de preparação, adesivo para aplicação de flavonoide, métodos de produção de flavonoide hidratado,métodos de preparação de formulação tópica, e uso de flavonoide
US8586567B2 (en) 2009-10-29 2013-11-19 Acasti Pharma, Inc. Concentrated therapeutic phospholipid compositions
IT1397386B1 (it) * 2010-01-12 2013-01-10 Indena Spa Composizioni a base di estratti di andrographis paniculata combinati con estratti di ginkgo biloba complessati con fosfolipidi e loro uso.
US20110262505A1 (en) 2010-04-22 2011-10-27 Gina Athwal Seaweed-derived cosmetic compositions
US20140093466A1 (en) 2012-10-02 2014-04-03 The Procter & Gamble Company Hair care compositions and methods of use
EP2763648B1 (en) * 2011-10-03 2017-11-29 The Procter and Gamble Company Hair care compositions and methods of use
DE202011108417U1 (de) 2011-11-29 2012-03-01 Ruth-Maria Korth Örtliche und dietätische Kompositionen ohne Etherlipide, Etherphospholipide, Alkylradikale, die geeignet sind für sensible Personen
KR20190090075A (ko) * 2012-05-22 2019-07-31 해럴드 고든 케이브 커큐민을 함유하는 개선된 복합체 및 조성물
US20150110866A1 (en) * 2012-05-22 2015-04-23 Harold Gordon Cave Complexes and compositions containing curcumin
CN102977164B (zh) * 2012-11-05 2015-09-30 河南牧翔动物药业有限公司 一种刺五加叶中金丝桃苷的酶辅助提取工艺
ITMI20130171A1 (it) 2013-02-07 2014-08-08 Velleja Res Srl Composizioni ergogenico-anabolizzanti a base di polygonum fagopyrum
CN105188850A (zh) 2013-05-16 2015-12-23 宝洁公司 毛发增稠组合物及使用方法
US9132117B2 (en) 2013-06-17 2015-09-15 Kgk Synergize, Inc Compositions and methods for glycemic control of subjects with impaired fasting glucose
US20160175377A1 (en) 2014-12-19 2016-06-23 Umm Al-Qura University Formulation and functionality of phenolipids for novel foods and pharmaceuticals
CN104983761A (zh) * 2015-06-15 2015-10-21 中国科学院长春应用化学研究所 一种刺五加叶总黄酮磷脂复合物及其制备方法以及制剂
WO2017020125A1 (en) 2015-07-31 2017-02-09 Delivra Inc. Transdermal formulations for delivery of capsaicinoids
EP3337482A4 (en) * 2015-08-17 2019-03-20 Delivra Inc. TRANSDERMAL FORMULATIONS FOR THE DISTRIBUTION OF BERBERIN COMPOUNDS AND THEIR USE IN THE TREATMENT OF BERBER INDEPENDENT ILLNESSES AND DISORDERS
CA2997220A1 (en) * 2015-09-03 2017-03-09 Delivra Inc. Transdermal formulations for delivery of doxycycline, and their use in the treatment of doxycycline-responsive diseases and conditions
US20190046481A1 (en) * 2015-09-18 2019-02-14 Delivra Inc. Transdermal formulations for delivery of propionic and acetic acid nsaids, and their use in the treatment of nsaid-responsive diseases and conditions
CA3024205A1 (en) * 2016-05-16 2017-11-23 Delivra Inc. Transdermal formulations for delivery of celecoxib and its use in the treatment of celecoxib-responsive diseases and conditions
EP3332768A1 (en) 2016-12-06 2018-06-13 INDENA S.p.A. Powder solid compositions comprising flavonoids, process for their preparation, formulations and use thereof
EP3697445A4 (en) 2017-10-16 2021-07-14 Delivra Inc. TRANSDERMAL FORMULATION FOR THE DELIVERY OF HYDROPHOBIC COMPOUNDS AND PROCEDURES FOR THEIR PRODUCTION
US11142492B2 (en) 2019-08-26 2021-10-12 Wisconsin Alumni Research Foundation Methods of isolating phenols from phenol-containing media

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2952115C2 (de) * 1979-12-22 1982-05-06 A. Nattermann & Cie GmbH, 5000 Köln Rosmarinsäure-Phospholipid-Komplex
JPS60208910A (ja) * 1984-03-31 1985-10-21 Green Cross Corp:The 水難溶性薬物・リン脂質複合体の製造方法
US4769508A (en) * 1984-12-18 1988-09-06 Atlantic Richfield Company Alkali promoted manganese oxide compositions containing titanium
IT1215291B (it) * 1985-07-17 1990-01-31 Inverni Della Beffa Spa Complessi di flavanolignani con fosfolipidi, loro preparazione e relative composizioni farmaceutiche.
IT1187687B (it) * 1985-07-17 1987-12-23 Inverni Della Beffa Spa Composizioni farmaceutiche contenenti come principi attivi flavanolignani e fosfolipidi
IT1201151B (it) * 1987-01-14 1989-01-27 Indena Spa Complessi fosfolipidici con estratti da vitis vinifera,procedimento per la loro preparazione e composizioni che li cntengono
JPH01152632A (ja) * 1987-12-09 1989-06-15 Nec Corp 半導体組立装置

Also Published As

Publication number Publication date
EP0275005B1 (en) 1993-08-11
EP0275005A3 (en) 1989-10-04
IT8719081A0 (it) 1987-01-14
JPS63198693A (ja) 1988-08-17
DE3883016D1 (de) 1993-09-16
ES2058139T3 (es) 1994-11-01
ATE92929T1 (de) 1993-08-15
US5043323A (en) 1991-08-27
DE3883016T2 (de) 1993-11-25
JP2848827B2 (ja) 1999-01-20
IT1201149B (it) 1989-01-27
EP0275005A2 (en) 1988-07-20

Similar Documents

Publication Publication Date Title
EP0275005A3 (en) Complex compounds of bioflavonoids with phospholipids, their preparation and use, and pharmaceutical and cosmetic compositions containing them
EP0283713A3 (en) Complexes of saponins with phospholipids and pharmaceutical and cosmetic compositions containing them
ZA896287B (en) Pharmaceutical combination preparations for use in anti-neoplastic therapy
NO170126C (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater i form av suspensjoner som inneholder sucralfat
FI830100A0 (fi) Nya 6-substituerade s-triazolo /3,4-a/ ftalazinderivat
CS653586A3 (en) Pharmaceutical containing 7-isopropoxyisoflavone
ZA885192B (en) Pharmaceutical preparations
IL89840A0 (en) Substituted flavonoid compounds and salts thereof,their preparation and pharmaceutical compositions containing them
PT86186A (en) Process for the preparation of benzimidazol derivatives and of pharmaceutical compositions containing the same
CA2163197A1 (en) Tri(platinum) complexes
IL88971A0 (en) Disubstituted pyridines,their preparation and pharmaceutical compositions containing them
IL84168A0 (en) Human factor viii-c analogs,process for the preparation thereof and pharmaceutical compositions containing the same
IL58103A0 (en) Sila-substituted 1,4-dihydropyridine derivatives their production and pharmaceutical compositions containing them
IL85189A (en) Beta-alkyl substituted melatonins,their preparation and pharmaceutical compositions containing them
IL87778A0 (en) Pharmaceutical compositions containing stabilized therapeutically active proteins and their preparation
IL106289A (en) Phospholipid derivatives their preparation and pharmaceutical compositions containing them
IL84551A (en) Peptides,their preparation and pharmaceutical compositions containing them
IL59295A (en) Dehydrophenylalanyl-tryptophan derivatives,their production and pharmaceutical compositions containing them
MY103593A (en) Bicyclic compounds, their use as pharmaceuticals, their preparation, and intermediates useful in their preparation
EP0316639A3 (en) Azelastin embonate, process for its preparation and pharmaceutical compositions containing azelastin embonate as the active ingredient
IL89015A0 (en) Tetrahydropyridine derivatives,their preparation and pharmaceutical compositions containing them
ATE96150T1 (de) Thioester und dessen verwendung zur herstellung von pharmazeutischen zusammensetzungen zur behandlung von ischaemie und von reperfusionsyndromen.

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20070104